Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MyCartis
Lausanne, Switzerland
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
MyCartis developed Evalution, a next-generation multiplex biomarker analysis platform designed for clinical research and pharmaceutical markets. The platform analyzes protein and nucleic acid-based biomarkers simultaneously using 40-micron binary-coded silicon microparticles for imaging and fluorescence detection. Currently intended for research purposes only, not for diagnostic procedures.[1][2]
- Therapeutic areas
- CardiovascularWomen's Health
- Modalities
- Protein analysis platformNucleic acid analysis platform
- Industry
- Drug Discovery Services
02
Partnerships
Invetech (instrument design and development partner)
Beyond the preview
Go deeper on MyCartis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MyCartis.